Related Experiment Video
Updated: Jul 14, 2026

Mouse Model of Pressure Ulcers After Spinal Cord Injury
Published on: March 9, 2019
Pressure ulcers: a role for thymosin beta4
1Virginia Commonwealth University School of Medicine, McGuire VA Medical Center, 1201 Broad Rock Blvd, Richmond, VA 23249, USA. Michael.Godschalk@VA.gov
Abstract:
Pressure ulcers occur in up to 14% of acute hospitalizations. They cause pain, decreased quality of life, increased morbidity, and prolonged hospitalizations. Treatment includes pain control, nutritional support, relieving pressure, removing devitalized tissue, and by using dressings and medications, providing an environment in which healing can occur. Even with optimal treatment, pressure ulcers may take months to heal. Thymosin beta4 is being investigated as a treatment for pressure ulcers. Thymosin beta4 has wound healing and anti-inflammatory properties. It is thought to exert its therapeutic effect through promotion of keratinocyte and endothelial cell migration, increased collagen deposition, and stimulation of angiogenesis. A study in a rat full-thickness wound model showed that treatment with thymosin beta4 increased collagen deposition and angiogenesis and stimulated keratinocyte migration and reepithelialization. If thymosin beta4 decreases healing time, this would represent a significant advance in the treatment of pressure ulcers.
Related Concept Videos
Diabetic Foot Ulcer
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
Peptic Ulcer Disease II: Pathophysiology
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Peptic Ulcer Disease II: Pathophysiology
Peptic Ulcer
